David M. Reese
About David M. Reese
David M. Reese is the Executive Vice President and Chief Technology Officer at Amgen, where he has worked for nearly 20 years and led the R&D organization since 2018.
David M. Reese's Role at Amgen
David M. Reese serves as the Executive Vice President and Chief Technology Officer at Amgen. Appointed as the first-ever Chief Technology Officer in late 2023, Reese has been a vital part of Amgen for nearly 20 years. In his current role, he oversees the company's technological advancements and strategic technological initiatives, ensuring that Amgen stays at the forefront of innovation in biopharmaceuticals.
David M. Reese's Leadership in R&D at Amgen
Since 2018, David M. Reese has been leading Amgen's Research and Development (R&D) organization. Under his leadership, Amgen has made significant strides in developing a robust pipeline of therapeutics. His guidance has been instrumental in driving innovation and bringing new products from concept to market, demonstrating his profound impact on the company's research endeavors.
David M. Reese's Background
David M. Reese is a physician-scientist who has made substantial contributions to the biopharmaceutical field. His extensive background in both clinical and scientific domains has equipped him with a unique perspective that he brings to his role at Amgen. His dual expertise enables him to bridge the gap between cutting-edge research and practical medical applications.
Development of Amgen's Robust Pipeline
Under the leadership of David M. Reese, Amgen has developed a robust research and development pipeline. His strategic vision and management have been pivotal in advancing numerous therapeutic candidates through various stages of clinical development. This focus on innovative pipeline growth ensures that Amgen continues to deliver significant breakthroughs in biopharmaceuticals.